Diabetes Self-Management Blog

The Accu-Chek Spirit insulin pump, manufactured in Switzerland by Disetronic Medical Systems (a subsidiary of Roche Diagnostics Corp.), is now available in the United States. The pump “system,” which includes the Spirit insulin pump, a Palm PDA with Accu-Chek Pocket Compass software, a choice of one of three Accu-Chek blood glucose meters, and a choice of carrying case, will begin shipping on October 30.

A “smartphone” with the Pocket Compass software can be substituted for the Palm PDA for an additional fee. The PDA and smartphone both feature a bolus calculator that can be used to program the pump remotely for bolus delivery, without necessitating removal of the pump from the user’s pocket, bra pouch, or wherever else it is worn.

The Accu-Chek Spirit pump holds 315 units of insulin, which is more than any other pump currently on the market in the United States. (The closest models hold 300 units.) It also features a reversible graphics display, meaning that the pump screen is never “upside down.” In addition, the Spirit pump uses a standard Luer lock connection, making it compatible with virtually all infusion sets, and is powered by one AA battery, which lasts about four weeks. To find out more about the pump’s specs, you can visit its Features & Specifications page.

The Accu-Chek Spirit pump is not a wholly new product—it is already sold and supported in 30 countries. It was not previously available in the United States because of an import alert issued in 2003 by the FDA expressing concerns about documentation and tracking of pump components at Disetronic’s facility in Switzerland. However, this alert has now been lifted after a more recent inspection of the site.

More information about the Accu-Chek Spirit pump system can be found at www.disetronic-usa.com.

POST A COMMENT       
  

We are currently experiencing technical difficulties with our commenting system. Thank you for your patience as we work to resolve them.


Insulin & Other Injected Drugs
New Weekly Type 2 Diabetes Drug Approved (09/26/14)
Dispelling the Myths of Insulin Therapy (08/01/14)
Insulin for Type 2 (07/14/14)
FDA Approves Inhalable Insulin (07/03/14)

Diabetes News
Mediterranean Diet May Benefit Kidneys (11/06/14)
New Metformin Combination Medicine Approved for Type 2 Diabetes (10/30/14)
FDA Approves Remote Glucose-Monitoring Technology (10/24/14)
Can Grapefruit Juice Prevent Weight Gain, Increase Insulin Sensitivity? (10/16/14)

 

 

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.